News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Inotuzumab ozogamicin with or without blinatumomab added to low-intensity chemotherapy
Photo: The Lancet Haematology/Twitter
May 18, 2023, 14:56

Inotuzumab ozogamicin with or without blinatumomab added to low-intensity chemotherapy

NEW: Inotuzumab ozogamicin with or without blinatumomab added to low-intensity chemotherapy showed promising activity in terms of PFS in older patients with B-cell ALL: results of a phase 2 trial

Source: The Lancet Haematology/Twitter

blinatumomab Inotuzumab ozogamicin phase 2 trial The Lancet Haematolog
Special Coverage
Blog
Nov 13, 2024, 14:55
Krish Patel has been appointed as the New Director of Lymphoma Research at SCRI
Blog
Nov 13, 2024, 14:49
Carmen Monge-Montero: Overcoming Cancer Without Discrimination - Opinion piece with Luis Fernando Solís Calvo
Blog
Nov 13, 2024, 14:47
Laura Samá: Don’t miss our posters at CTOS2024
Blog
Nov 13, 2024, 14:43
How climate change disrupts cancer services and threatens progress - UICC
Blog
Nov 13, 2024, 14:37
Don't miss out on the 2025 ASCO Voices session
Blog
Nov 13, 2024, 14:37
Help young people like Eric spread awareness and advocate for more research - Oncogene Cancer Research
Blog
Nov 13, 2024, 14:05
Tala Mahmoud: Honored to be selected as Reviewer of the Month by ACGCRJ
Blog
Nov 13, 2024, 12:13
Sarah Briggs: Cancer control in the face of climate change
Blog
Nov 13, 2024, 11:56
HER2-Low Status and Its Impact on Outcomes in Early-Stage Triple-Negative Breast Cancer
Blog
Nov 13, 2024, 11:52
Andrew Pannu: Analysis of Big Pharma Therapeutic M&A Deals from 2019 to today
Blog
Nov 13, 2024, 11:48
Indoor cooking with solid fuels can increase lung cancer risk - IASLC
Blog
Nov 13, 2024, 11:44
Registration for the AACR Annual Meeting 2025 is now open